Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

The status of pharmacotherapy for autism spectrum disorders.

Myers SM.

Expert Opin Pharmacother. 2007 Aug;8(11):1579-603. Review.

PMID:
17685878
2.

Pharmacotherapeutic management of autism.

Posey DJ, McDougle CJ.

Expert Opin Pharmacother. 2001 Apr;2(4):587-600. Review.

PMID:
11336609
3.

The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.

Posey DJ, McDougle CJ.

Harv Rev Psychiatry. 2000 Jul-Aug;8(2):45-63. Review.

PMID:
10902094
4.

Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.

Kolevzon A, Mathewson KA, Hollander E.

J Clin Psychiatry. 2006 Mar;67(3):407-14. Review.

PMID:
16649827
5.

Treatment of aggression in children and adolescents with autism and conduct disorder.

McDougle CJ, Stigler KA, Posey DJ.

J Clin Psychiatry. 2003;64 Suppl 4:16-25. Review.

6.

Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders.

Soorya L, Kiarashi J, Hollander E.

Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):753-71, viii. doi: 10.1016/j.chc.2008.06.003.

PMID:
18775368
7.

Pharmacologic treatment for the core deficits and associated symptoms of autism in children.

West L, Waldrop J, Brunssen S.

J Pediatr Health Care. 2009 Mar-Apr;23(2):75-89. doi: 10.1016/j.pedhc.2008.12.001.

PMID:
19232924
8.

Role of risperidone in children with autism spectrum disorder.

Chavez B, Chavez-Brown M, Rey JA.

Ann Pharmacother. 2006 May;40(5):909-16. Epub 2006 Mar 7. Review.

PMID:
16684811
9.

Children and autism--Part 1--recognition and pharmacological management.

Angley M, Young R, Ellis D, Chan W, McKinnon R.

Aust Fam Physician. 2007 Sep;36(9):741-4. Review.

PMID:
17915375
10.

Psychopharmacology of autistic spectrum disorders in children and adolescents.

Nazeer A.

Pediatr Clin North Am. 2011 Feb;58(1):85-97, x. doi: 10.1016/j.pcl.2010.10.011. Review.

PMID:
21281850
11.
12.

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.

McDougle CJ, Scahill L, McCracken JT, Aman MG, Tierney E, Arnold LE, Freeman BJ, Martin A, McGough JJ, Cronin P, Posey DJ, Riddle MA, Ritz L, Swiezy NB, Vitiello B, Volkmar FR, Votolato NA, Walson P.

Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):201-24. Review.

PMID:
10674197
13.

Psychopharmacology in autism: an update.

Canitano R, Scandurra V.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15;35(1):18-28. doi: 10.1016/j.pnpbp.2010.10.015. Epub 2010 Oct 27. Review.

PMID:
21034789
14.

Pharmacologic treatment of autism.

Palermo MT, Curatolo P.

J Child Neurol. 2004 Mar;19(3):155-64. Review.

PMID:
15119475
15.

Review of the evidence for treatment of children with autism with selective serotonin reuptake inhibitors.

West L, Brunssen SH, Waldrop J.

J Spec Pediatr Nurs. 2009 Jul;14(3):183-91. doi: 10.1111/j.1744-6155.2009.00196.x. Review. Erratum in: J Spec Pediatr Nurs. 2009 Oct;14(4):301-2.

PMID:
19614827
16.

Pharmacotherapy of children and adolescents with pervasive developmental disorders.

Hanft A, Hendren RL.

Essent Psychopharmacol. 2004;6(1):12-24. Review. No abstract available.

PMID:
15612651
17.

Is there a basis for novel pharmacotherapy of autism?

Hunsinger DM, Nguyen T, Zebraski SE, Raffa RB.

Life Sci. 2000 Aug 25;67(14):1667-82. Review.

PMID:
11021352
18.

Children with autism spectrum disorders and intellectual disability.

McCarthy J.

Curr Opin Psychiatry. 2007 Sep;20(5):472-6. Review.

PMID:
17762590
19.

An update on pharmacologic treatments for autism spectrum disorders.

King BH, Bostic JQ.

Child Adolesc Psychiatr Clin N Am. 2006 Jan;15(1):161-75. Review.

PMID:
16321729
20.

Safety issues with drug therapies for autism spectrum disorders.

McCracken JT.

J Clin Psychiatry. 2005;66 Suppl 10:32-7. Review.

Supplemental Content

Support Center